TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 2 | -4 | -5 | -24 | -62 | -67 | -27 |
| S | %wins | 0 | 100 | 100 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/22/09 15:18 | 5/21/09 | SCLN | Sciclone Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Baxter John D | CA | D | M.d | 14 | 1.44 | 0 | 10 | 3 | 371 | D | -38 | -1 | 107 | 56 | 11 | 11 | -6 | -3 | 6 | 36 | 16 | 124 | 63 | 103 | |
8/15/05 14:51 | 8/11/05 | SCLN | Sciclone Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Baxter John D | CA | D | S | -48 | 6.00 | 7 | -8 | -2 | 361 | I | -19 | 82 | 74 | 141 | 31 | -9 | -21 | 14 | 2 | -4 | -5 | -24 | -62 | -67 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |